Commercialise research into Parkinsonian movement disorders, Alzheimer's disease, Huntington disease and other neurodegenerative disorders.
|Head Office||Melbourne VIC|
|Registry||Computershare Investor Services Pty Ltd|
|Chair Person||Geoffrey Kempler|
|GICS Industry||Pharmaceuticals, Biotechnology & Life Sciences|
|Market Cap||$27 m|
|Shares on Issue||2,416 b|
|52 Week H/L|
Directors and Management
Mr David Sinclair
Non-Executive Director 08/04/2019
Dr Sinclair is the co-founder and chairman of Life Biosciences LLC. He is also a tenured professor in the Department of Genetics at Harvard Medical School, a co-director of the Paul F. Glenn Center for the Biology of Aging Research, and serves on the non-profit boards of the American Federation for Aging Research and the Sanford Lorraine Cross Award. He has co-founded biotechnology and genomics companies which work on aging, neurological, metabolic, infectious and rare diseases.
Ph.D., AO Accountant Male
Mr Geoffrey Paul Kempler
Non-Executive Chairman,Non-Executive Director 16/06/2005
Mr Kempler has served as our Chief Executive Officer, and in June 2005 he again assumed the position of Chief Executive Officer. Mr Kempler has experience in investment and business development, has been in charge for the implementation of our strategic plan and the commercialisation of our technology.
B.Sc. Grad. Dip. App. Soc. Psych Psychologist Male
Mr Brian Derek Meltzer
Non-Executive Director 09/12/1999
Mr Meltzer spent 25 years in investment banking. His breadth of expertise includes property transactions, corporate advisory, corporate finance, management buyouts, venture capital and syndications. He has held a number of Board and Board Advisory roles for private companies in the human resources, health, aged care, software, entertainment and finance sectors, including Director of a federal government Innovation Investment Fund. Mr Meltzer is also a Director of the Australia-Israel Chamber of Commerce, Chairman of Independence Australia and Chairman of a privately owned corporate health and wellness business.
B. Com., M Ec Banker Male
Mr Peter Ashley Marks
Non-Executive Director 29/07/2005
Mr Marks for over 13 years until the end of August 2014 was a Director of Peregrine Corporate Ltd, an Australian-based investment banking and corporate advisory firm. Mr Marks was until 2016, a Director of Armadale Capital Plc, which has focus on natural resources projects based in Africa with its current investments being a gold exploration company in DRC and a coal briquetting operation in South Africa. Mr Marks is currently a Consultant at Henslow Pty Ltd, a corporate and capital markets advisory firm. Mr. Marks is also a nonexecutive director of Terragenic International Ltd, an unlisted public company and has develop a novel hydrogen fuel system. From September 1998 until March 2001, Mr Marks was working with KPMG Corporate Finance Ltd (Australia), where he rose to Director and was in charge for heading up the equity capital markets group in Melbourne. From January 1992 until July 1994, Mr. Marks served as Head of the Melbourne Companies Department at the ASX and was founding Director of Momentum Funds Management Pty Ltd, an Australian venture capital firm. From December 1990 until December 1991, Mr Marks served as Director of Corporate Finance at Burdett Buckeridge & Young Ltd in their Melbourne offices, from August 1988 until November 1990, he held senior corporate finance position at Barings Securities Ltd, and from July 1985 until July 1988, he served as an Associate Director of McIntosh Securities, now Merrill Lynch Australia. In his roles with these financial institutions, Mr Marks was in charge for advising a number of listed and unlisted companies on issues ranging from corporate and company structure, to valuation, business strategies, acquisitions and international opportunities.
BEco, LLB, MBA,GradDipCommLaw Male
Mr Lawrence Gozlan
Non-Executive Director 08/08/2011
Mr Gozlan is the Chief Investment Officer and Founder of Scientia Capital, a investment fund which has focus in life sciences. Prior to this, Mr Gozlan was in charge for the biotechnology investment portfolio in Australia as the institutional biotechnology analyst at QIC ("the Queensland Investment Corporation"). He previously worked as the senior biotechnology analyst in the equities team at Foster Stockbroking Pty Ltd, and gained senior corporate finance experience advising life sciences companies at Deloitte. Mr Gozlan is currently direcor of number of private biotechnology companies in the USA.
BSc.(Hons) Biotechnology Investor, Advisor Male
Mr Tristan Edwards
Non-Executive Director 08/04/2019
Mr Edwards is the co-founder and President of Life Biosciences LLC. He has financial capital markets, regulatory compliance, and fiduciary oversight experience, following a 16 year investment career spanning financial organizations across Australia, London, HK and Singapore. His background has been in senior investment roles at financial groups such as Goldman Sachs, Brevan Howard, Trafalgar Capital and Mosaic Asset Management. He started his career as an analyst with the Australian Commonwealth Department of Finance.
BCom, CFA, CMT, CPA Male
Top 20 Shareholders
|1.||HSBC Custody Nominees (Australia) Limited||1,358,556,242||56.44|
|2.||Life Biosciences Llc||269,905,533||11.21|
|3.||Jagen Pty Ltd||38,556,497||1.60|
|4.||1215 Capital Pty Ltd||18,733,028||0.78|
|5.||Rentuk Shore Pty Ltd||15,641,719||0.65|
|6.||Capuano Nominees Pty Ltd (The Hartman Investment A/C)||15,000,000||0.62|
|7.||Andrew Mark Wilmot Seton||14,795,663||0.61|
|8.||Citicorp Nominees Pty Limited||14,394,030||0.60|
|9.||Baywick Proprietary Limited (The Retail Discretionary A/C)||14,165,000||0.59|
|10.||BNP Paribas Nominees Pty Ltd Acf Clearstream||12,164,297||0.51|
|11.||Fagan Harris Pty Ltd (Fagan Harris Super Fund A/C)||9,500,000||0.39|
|12.||Mr Benjamin Woolvett||7,210,000||0.30|
|13.||Mr Bill Konstad & Mrs Despina Konstad (The B&D Konstad S F Ac)||6,195,856||0.26|
|14.||Mr David John Southon (Southon Family A/C)||6,000,000||0.25|
|15.||Mr Minh Huy Lam||6,000,000||0.25|
|16.||Mr Huy Nguyen (Huy Nguyen Super Fund A/C)||5,380,195||0.22|
|17.||Mr Anurag Pandey||5,020,000||0.21|
|18.||Citos Super Pty Ltd (Citos Pty Ltd Sf A/C)||5,000,000||0.21|
|19.||Mr Christopher Robert Schroeter||4,778,958||0.20|